Niger

in page functions
Total population (2013) 17,831,270
Birth cohort (2013) 889,574
Surviving Infants (surviving to 1 year per year, 2013) 842,905
Infant mortality rate (deaths < 1 year per 1000 births, 2012) 63/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012) 114/1000
World Bank Index, IDA (2012) 3.39
Gross Nation Income (per capita US$, 2012) 370
Co-financing status (2013) Low-income
No. of districts/territories (2012) 42

GAVI support for Niger

Type of support

Approvals

2001-2017 (US$)
(31 Dec 2013)

Commitments

2001-2017 (US$)
(31 Dec 2013)

Disbursements

2000-2013 (US$)
(31 Dec 2013)

% Disbursed

(31 Dec 2013)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015
Cash Support $235,000 $260,000 $235,000 100%
Health system strengthening (HSS) $3,986,000 $3,986,000 $3,986,000 100%
HPV Demo (NVS) $630,760 $630,760 $312,513 50%
Immunisation services support (ISS) $8,055,365 $8,055,365 $8,055,365 100%
Injection safety support (INS) $943,757 $943,757 $943,757 100%
Penta (NVS) $39,526,912 $45,382,412 $37,608,464 95%
Pneumo (NVS) $23,536,570 $40,241,070 $11,957,158 51%
Rotavirus (NVS) $5,433,000 $9,958,500 $3,788,238 70%
Vaccine Introduction Grant $2,061,500 $2,061,500 $2,061,500 100%
Yellow Fever (NVS) $2,638,792 $3,733,292 $2,181,533 83%
Total $87,047,656 $115,252,656 $71,129,528

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Niger DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2012)

Grade of confidence
74%

*
DTP3 - Official country estimates (2012) 96%
M:F sex ratio at birth (2013) 1.05
Household survey: DTP3 coverage for male (2011) 67.50%
Household survey: DTP3 coverage for female (2011) 68.60%
Household survey: Last DTP3 survey (2011) 68%
% districts achieving > 80% DTP3 coverage (2012) 98%
% districts achieving < 50% DTP3 coverage (2012) 0%
MCV WHO/UNICEF estimates (2012) 73%
Polio WHO/UNICEF estimates (2012) 78%

Breakdown of support

Non-vaccine support Vaccine support
21% 79%
$15,281,621 $55,847,904

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Niger

29 May 2013

WomenDeliverSeth.jpg

Vaccines against cervical cancer and rubella to benefit health of women and girls

Two new vaccines that help protect against cervical cancer, measles and rubella spearhead the GAVI Alliance’s commitment to improving the health of girls and women.

28 May 2013

Global Forum Cervical Cancer - Seth

Voices from the Global Forum on Cervical Cancer Prevention

Over 400 Government leaders, policymakers, healthcare professionals, NGOs and corporate leaders gathered for the first-ever Global Forum on Cervical Cancer Prevention on 27 May.

14 May 2013

Mariam

Kenya first country to protect girls against cervical cancer with GAVI support

Kenya becomes the first country to protect girls against cervical cancer with GAVI-supported human papillomavirus (HPV) vaccines.

close icon

modal window here